Recent research sheds light on a molecular link between B12 deficiency and multiple sclerosis, opening the door to the possibility of new ways to treat MS.
Epstein-Barr disease stretches further than the infectious mononucleosis—with frequently overlooked influence on chronic diseases such as multiple sclerosis.